Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.

Slides:



Advertisements
Similar presentations
Managing Sick Days and Hospital Stays Mike Heile MD Orlando, CWD July, 2011.
Advertisements

Making The Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE
Making The Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE
Do you require any assistance? Do you experience any symptoms? Calit2 Summer Research Program Minimize Hypoglycemic Episodes Utilizing Remote Assistance.
In the name of GOD In the name of GOD.
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Insulin Pump What to tell your patient!! Prakash Abraham Isla Fairley.
Continuous Glucose Monitoring
PRACTICAL ASPECTS OF CONTINUOUS GLUCOSE MONITORING (CGM) Barb Tallant, RN, MA Laurel Messer, RN, BSN, CCRP.
DAVID C KLONOFF, MD Medical Director Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services Clinical Professor of.
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Diabetes Update: Living Life after Lente
1 INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS H. Peter Chase, MD Vicky Gage, RN, CDE Laurel Messer, RN, CDE Susie Owen, RN, CDE Sally Sullivan, RN, CDE.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Management Tools and CGM Kathryn Moe, RN CDE Medtronic Diabetes.
Pumps and Sensors In the School Setting. 2 Agenda Comparison of available insulin pumps Continuous glucose monitors Pump therapy & CGM in the school setting.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Choosing a Blood Glucose Meter Why, When, How, and What Presented by Ron Kammer RN CDE.
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Diabetes Technology Update
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
Making the Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE Owner & Clinical Director Integrated Diabetes Services LLC Wynnewood, PA AADE 2014.
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Continuous Glucose Monitors
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Healthcare Across Borders - September 2003 Head-To-Head Comparison Of The Two Currently Available Continuous Monitors North County Endocrine 700 West El.
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Source:
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
The Super Bolus And The Projected BG Alert New Insulin Pump Ideas To Improve Glucose Levels, Avoid Hypoglycemia And Speed Correction Of Hyperglycemia John.
Special Situations In The Management Of In-Patient Hyperglycemia
Gerti Tashko, M.D. DM Journal Club 12/16/2010. The use of exenatide with insulin is not FDA approved. The study was designed to evaluate if exenatide.
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Monitoring and Management Jennifer Danielson, PharmD, MBA, CDE Clinical Assistant Professor University of Washington School of Pharmacy.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
 History of advancement in diabetes treatment  New technology  Features  Pros and Cons  Safety in school  Questions.
Key publication slides
Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO
Copyright © 2004 American Medical Association. All rights reserved.
Making the Most of Continuous Glucose Monitoring
Living with Diabetes Presentation Overview: Diagnosis
Today we are going to cover….
Clinical Performance.
Diabetes Care Tasks at School: What Key Personnel Need To Know
Components of a CGM record over a 3
Today we are going to cover….
A review of the new Eversense CGM System
Study Objective & Methods
Pharmacist Involvement in Continuous Glucose Monitoring
Campbell FM, et al. Pediatr Diabetes. 2018;19(7):1294–1301
Introduction to Continuous Glucose Monitoring
Practical Implementation and Optimization of A Closed Loop System
Presentation transcript:

Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes

Presentation Outline Historical background Accuracy & research Insurance coverage for pediatrics Barbara Davis Center experience Real-Time and retrospective use of CGM Practical child and family issues

CGM Historical Background

CGMS® –FDA- approved in 1999 – Retrospective review of downloaded data –Principle: Glucose oxidase-coated subcutaneous sensor Glucowatch Biographer –FDA- approved in 2001 –First approved real time device –Principle: reverse iontophoresis through intact skin

Real Time Continuous Glucose Monitoring Freestyle Navigator Dexcom STS Paradigm Real Time System

Continuous Glucose Monitors The DirecNet experience

Inpatient Accuracy Study Principal Aim: To assess the accuracy of the Medtronic MiniMed CGMS and the GlucoWatch Biographer II vs. gold standard plasma glucose measurements in children with T1DM

Subject Demographics 91 Children and Adolescents 91 Children and Adolescents 51% Female 51% Female 43% Pumpers 43% Pumpers Mean HbA1c = 7.8% Mean HbA1c = 7.8%

Daily Glucose Variations Procedure Regular meals and insulin doses GS glucose q30-60 min

Results nr Mean RAD Median RAD Within ISO GWB 3, %16%80% CGMS (original) 5, %19%53% CGMS (Modified) 1, %11%72% Ultra2, %9%94% ISO Criteria: If reference glucose ≤ 75 mg/dL, sensor glucose within ± 15 mg/dL; if reference glucose > 75 mg/dL, sensor glucose within ± 20%. Diabetes Technology &Therapeutics Vol 5 (5), 2003

Factors NOT Impacting Accuracy For Either the GW or CGMS Age of the Subject BMI (body mass index) Sensor age (CGMS) Location of GWB placement –Upper vs lower arm –Inner vs outer arm

Sensor Accuracy by Glucose Level

CGMS Sensitivity and False Alarm rate for detection of hypoglycemia Alarm Setting SensitivityFalse Alarm Rate (mg/dl) 6049%58% 8084%64% %75% %84%

Down alert Only 24% and 8% of truly hypoglycemic incidents were detected by the simple alarm during the hypoglycemia test and overnight, respectively Combining the simple alarm with the down alert improves those sensitivity rates to 88% and 77%, respectively Diabetes Technol Ther Oct; 6(5):

Accuracy of the Freestyle Navigator and Guardian RT Diabetes Care Jan; 30 (1):59-64

Results n Median RAD Within ISO Guardian RT1,43414% 64% Navigator 1,811 12%74% Ultra 2,068 9%94% ISO Criteria: If reference glucose ≤ 75 mg/dL, sensor glucose within ± 15 mg/dL; if reference glucose > 75 mg/dL, sensor glucose within ± 20%.

These devices have sufficient accuracy to allow tracking of glucose values However, neither device is as accurate as meters presently available on the market Particularly useful for detecting post- prandial glycemic excursions and overnight glucose trends Conclusions

GWB2 Randomized Controlled Trial Diabetes Care May; 28(5):1101-6

HbA1c

Ultra Daily Use First Month:5.1 ± 1.6 in Usual Care group, 5.6 ± 1.7 in GWB group Third Month:5.1 ± 1.8 in Usual Care group, 5.3 ± 1.6 in GWB group Sixth Month:4.8 ± 1.7 in Usual Care group, 5.1 ± 1.7 in GWB group

GW2B use First Month:2.1 ± 0.8 uses per week (64% = at least 2 sensors/ week) Third Month: 1.6 ± 0.7 uses per week (7 of the 99 subjects discontinued GW2B use) Sixth Month: 1.5 ± 0.6 uses per week (26 of the 98 subjects discontinued GW2B use) Questionnaire regarding non-use of the GW2B (55 subjects) 76% = “skin irritation” 56% = “skips too frequently” 47% = “alarms too frequently” 33% = “readings not accurate” 31% = “too busy to use it” 22% = “forget to use it” 18% = “did not help with diabetes management”

Lesson learned: For CGM to help with diabetes management, patients must use them!

Freestyle Navigator Pilot trial Journal Pediatr Oct; 151 (4):

Summary 57 pediatric subjects enrolled –30 Pumpers –27 MDI A1c data collected at 13 weeks Voluntary sensor use offered after 13 weeks 73% of pump users continued to use sensor at 12 months and 78% of MDI users continued at 10 months (median hrs/wk 98 and 85 respectively)

A Randomized Clinical Trial to Assess the Efficacy of Real- Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes funded by a grant from the Juvenile Diabetes Research Foundation

Clinical Trial Design  450 subjects age >=8 years 330 with A1c >7.0% and 120 with HbA1c <7.0% 1/3 in each age group: % pump users, 50% MDI  Randomization to RT-CGM or Usual Care Navigator, DexCom, Paradigm/Guardian REAL-Time  Primary outcome at 6 months  Months 7-12: both groups use RT-CGM  Outcomes: HbA1c, hypoglycemia, quality of life  Cost-effectiveness ancillary study

Current status JDRF RCT 6 month data collection already completed 12 month data collection still in progress.

Insurance coverage for pediatrics Currently only one device approved for pediatric use Real time technology not universally covered Some success with approval on case by case basis Usually approved on appeals process

Presentation Outline RT- CGM systems for pediatrics Accuracy & research Insurance coverage for pediatrics Barbara Davis Center experience Real-Time and retrospective use of CGM Practical child and family issues

Barbara Davis Center experience with CGM Currently: 100+ pediatric pts on CGM 5 years old through adulthood Commercially: Paradigm REAL-Time, Dexcom SEVEN Research: Navigator Varied experiences with devices

Using a sensor on daily basis Insert sensor (every 3-7 days) Warm up period with no glucose readings Entering fingerstick BG for calibrations Device starts reading REAL-TIME information Occasional downloading of device for RETROSPECTIVE information

Real Time CGM Use SENSOR glucose levels Different from BG levels due to lag time Updates every 1-5 minutes ArrowsAlarms Trend information

Real Time CGM Use EDUCATION POINT: –Must always do a BG for insulin, treatment and management decisions WHY? No device currently FDA approved for replacement therapy Sensor may not be reading accurately

Retrospective data Downloaded at home or in clinic (anyone have experience with this?)

Retrospective data EDUCATION POINTS Must know the WHY before knowing WHAT to change! Make dosing changes if BG/SG is out of range 2 out of 3 days Important to look at trends Look at most recent week Questions before changing: missed bolus? menses? Illness? Bad pump set? Mistake in dose? Sports?

Retrospective data Trend graph (sensor daily overlay, modal day)

Coming soon: JDRF online CGM school!

Pediatric issues Expectations Sensor sticking SportsAlarmsCalibrations Family dynamics

Pediatric issues Expectations Expectations No fingerstick BGs Will read from the moment you put on Alarms will prevent all highs and lows Reality: 4-8 BGs per day Periods where not calibrated, not reading Sensor errors for no reason Alarms annoying

Pediatric issues Sensor sticking Three main problems: 1) Sensor does not stick Try different types of preps (IV prep, skin prep, Skin Tac, Mastisol, tincture of benzoine 2) Tape or preps causes skin reactions Try different preps or tapes Use IV3000/Tegaderm FIRST, and cut hole for sensor to insert through 3) Not enough skin “real estate” Try different sensors Pinch up even if not indicated Chart on handout Chart on handout

Pediatric issues Sensor sticking

Placement Consider where least impact and movement Arm– can cover with ace bandage for extra support (take off at night) Sweating Use antiperspirant under tape Breaking Never take CGM receiver out into game Pediatric issues Sports PROBLEM: CGM sensors fall off, sweat off, get broken

Calibration reminder * Calibration error * Replace sensor * High Glucose * Low Glucose * Projected Low Glucose * Projected High Glucose * Meter BG Now * Sensor end * W Calibration reminder * Calibration error * Replace sensor * High Glucose * Low Glucose * Projected Low Glucose * Projected High Glucose * Meter BG Now * Sensor end * Weak signal * Disconnected * Low transmitter * Bad transmitter * Sensor error * Bad sensor Pediatric issues Alarms Alarms can become overwhelming/ annoying Why?.... PROBLEM: Alarms can become overwhelming/ annoying Why?....

HIGH ALARM: mg/dl* LOW ALARM: mg/dl Consider higher with hypoglycemia unawareness Can gradually “tighten” alarms as glucose levels get tighter * My opinion only! Pediatric issues Alarms GOAL: Set alarms that are MEANINGFUL and will NOT drive the child crazy!

Can I change the type of alarm notice?” Navigator: YES: vibrate or sound at three different volumes Medtronic: YES: vibrate or sound at different volumes Dexcom: NO: Will first vibrate then sound at increasing volumes Pediatric issues Alarms

Solution: Improvise! On bedside table (in a glass) or under pillow on vibrate In hallway outside of room Baby monitor Sibling in the room! Spy equipment Paradigm Real-Time: More difficult because usually under blankets– new tech coming soon! Pediatric issues Overnight alarms Parent/child has difficulty hearing alarms at night PROBLEM : Parent/child has difficulty hearing alarms at night

Pediatric issues Calibrations GOAL: Be the BOSS of the Calibration: Only enter a calibration if BGs are STABLE SOLUTION: Calibrate before meals or 2 hours after food or insulin shot –Less likely to get a failed calibration alarm –More likely to get accurate sensor readings Calibration alarms annoying, inconvenient, and when fail, are frequent PROBLEM : Calibration alarms annoying, inconvenient, and when fail, are frequent

Family issues and dynamics Adaptation: “It is just part of our life now. I wear it all the time and don’t think much about it anymore.” 12 y.o. female Anxiety: “ I was worried that my mom was mad at my blood sugars all the time so I didn’t want to show her” 11 y.o. male Ambivalence: “I like it when it works but I worry it is going to fall out and I will have to put a new sensor in again” 14 y.o. male

Family issues and dynamics THE BOTTOM LINE: They have to live with diabetes, not with CGM Interval wear (example: 1 sensor/week) Occasional wear (example: during finals) Try again later

The future of CGM Smaller Longer sensor wears Less calibrations More insurance coverage Closed loop system (insulin pump responds to sensor glucose levels) Implantable sensors

Questions?